DRUG · Mapped RxNorm record
Pioglitazone 45 mg
Normalized identity: pioglitazone 45 MGView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia
NCT05919147
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThe Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
Pioglitazone 45 mgDRUG · verified · RxNorm: pioglitazone 45 MG
PlaceboDRUG
Sponsors & collaborators
Pennington Biomedical Research Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05919147 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.